Information for Patients
Our goal is to find connections or links to cancer diagnoses, so that in the future we can develop better treatments by collecting data and biospecimens on adult cancer patients, high-risk individuals and healthy controls.
Thank you for considering enrolling into the iCaRe2.
What is translational research?
Translational research is the process of translating scientific findings into therapeutic treatments. Researchers study a disease in the lab and develop tools for physicians to try in clinical trials. During the trials, the physicians chart the effects in patients, which in turn impacts research efforts. This is often referred to as the bench-to-bedside approach because it helps patients receive new and improved treatments as quickly as possible.
The information gathered from the iCaRe2 registries and biobank helps researchers gain a better understanding of specific cancer types, determine risk factors, advance treatment for patients and their families and discover prognostic markers for cancer. The registry identifies participants who might benefit from screening measures for early detection which may lead to more options for treatment.
What can our genetic makeup tell us about our chances of developing cancer? Are there environmental factors to be aware of? Should I be concerned that my family is at a higher risk? The iCaRe2 is a system that can help answer these and other important questions.
- Provide your demographic, lifestyle, medical and family history information for the registry as well as biospecimens for the biobank.
- Continue annual follow-up with your health care provider so information can be obtained on disease or its spread, recurrences or additional malignancies, subsequent treatment, and quality of life.
- Encourage other cancer survivors and their family members to enroll.
To find a participating center near you, please view the list of participating centers or feel free to contact the iCaRe2 coordinator for more information.
To be eligible, individuals must meet the following criteria:
- Older than 19.
- Able to provide informed consent.
If you'd like to participate, you can start the enrollment process at UNMC/Nebraska Medicine.
Participation in the iCaRe2 is entirely voluntary. There is no charge to the subject and no compensation for participation in the registry.
If you have any questions, please feel free to contact us.
Michelle Desler
Lead Coordinator
402-559-8885